Lumida
/SNWV
⌘K
SANUWAVE Health Inc

SANUWAVE Health Inc

SNWV
$4.10USD+2.50%+0.10 today

MARKET CAP

35.3M

P/E (TTM)

12.4x

FWD P/E

DAY RANGE

$4 – $4

52W RANGE

$4
$41

AI Summary

Stalk
TrimMedium

In a Stage 4 decline, both medium- and long-term biases remain bearish. Despite an extreme oversold bounce, price is still below the downward-sloping 9/21 EMAs without any clear rejection at resistance levels. With no definitive short-side trigger, execution should be deferred, awaiting a pullback into the EMA zone for a structurally sound short entry.

  • UltraMist system taps growing wound care demand and rising consumable sales
  • Low debt supports sustained R&D and marketing investments
  • Q2 revenue $9.6–$9.8M fell 3–5% from prior year
Full analysis →

Buying

4

institutions

Selling

2

institutions

New Positions

1

this quarter

Filing Period

Q2 2026

latest 13-F

13-F Holdings

InstitutionActionShares HeldValueChangeChg %Weight
PP

Praetorian Pr LLC

Q2 2026

BUY395.00 K3.95 M+45.00 K-34.7%1.26%
BI

Blackrock, Inc.

Q2 2026

SELL159.87 K1.60 M+-321.67 K-80.8%0.00%
CA

Citadel Advisors LLC

Q2 2026

BUY59.47 K594.73 K+41.38 K+90.1%0.00%
JC

Jpmorgan Chase & Co

Q2 2026

BUY39.70 K391.01 K+36.65 K+637.7%0.00%
AC

Aqr Capital Management LLC

Q2 2026

BUYNEW22.91 K229.08 K+22.91 K+0.0%0.00%
MM

Millennium Management LLC

Q2 2026

SELL16.93 K169.25 K+-7.74 K-60.3%0.00%